| Ardea Resources Limited (ARL) ORDINARY FULLY PAID |
Materials |
$152 |
Proposed issue of securities - ARL
|
3 Mar 2026 9:18AM |
$0.680 |
$0.690 |
risen by
1.47%
|
|
| Ardea Resources Limited (ARL) ORDINARY FULLY PAID |
Materials |
$152 |
Successful $5M Placement and launch of Share Purchase Plan
|
3 Mar 2026 9:18AM |
$0.680 |
$0.690 |
risen by
1.47%
|
|
ARL - Price-sensitive ASX Announcement
Full Release
Key Points
- Successful A$5 million placement to professional and sophisticated investors.
- Launch of a A$2 million Share Purchase Plan (SPP) for eligible shareholders.
- Funds raised to support the Kalgoorlie Nickel Project's Goongarrie Hub DFS and related activities.
- Placement and SPP shares priced at A$0.60 per share.
- Petra Capital Pty Limited acted as Sole Lead Manager and Sole Bookrunner.
- SPP allows eligible shareholders to apply for up to A$30,000 in shares.
- Company reserves the right to accept oversubscriptions or scale back applications.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Everlast Minerals Ltd. (EV8) ORDINARY FULLY PAID |
Materials |
$22 |
Official demarcation and handover of Kurigram site
|
3 Mar 2026 9:16AM |
$0.450 |
$0.400 |
fallen by
11.11%
|
|
| Echelon Resources Limited (ECH) ORDINARY FULLY PAID |
Energy |
$81 |
ECHELON EXTENDS TERMS SHEET DEADLINE
|
3 Mar 2026 9:16AM |
$0.370 |
$0.360 |
fallen by
2.70%
|
|
| Nanosonics Limited (NAN) ORDINARY FULLY PAID |
Health Care |
$998 |
Update - Notification of buy-back - NAN
|
3 Mar 2026 9:16AM |
$3.390 |
$3.340 |
fallen by
1.47%
|
|
| Magnetite Mines Limited (MGT) ORDINARY FULLY PAID |
Materials |
$7 |
Renounceable Rights Issue to Raise up to $3.92 Million
|
3 Mar 2026 9:16AM |
$0.050 |
$0.029 |
fallen by
42%
|
|
MGT - Price-sensitive ASX Announcement
Full Release
Key Points
- 1 for 2 renounceable rights issue to raise up to $3.92 million
- Issue price of $0.04 per share with a 20% discount to last closing price
- Each new share includes one free attaching option with a $0.08 exercise price
- Partially underwritten to $0.8 million by Mahe Capital
- Funds to be used for exploration and Razorback Project development
- Rights issue is open to shareholders in Australia and New Zealand
- Shareholders can trade their rights on the ASX
- Directors will participate in the rights issue
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ansell Limited (ANN) ORDINARY FULLY PAID |
Health Care |
$3,632 |
Appendix 3X - Jonas Samuelson
|
3 Mar 2026 9:16AM |
$32.260 |
$25.710 |
fallen by
20.30%
|
|
| Albright Metals Ltd (ABR) ORDINARY FULLY PAID |
Materials |
$4 |
Presentation - Canada's Atlantic Edge at PDAC 2026
|
3 Mar 2026 9:15AM |
$0.004 |
$0.003 |
fallen by
25%
|
|
| WCM Global Growth Limited (WQG) ORDINARY FULLY PAID |
Financials |
$515 |
Weekly NTA 27 February 2026
|
3 Mar 2026 9:15AM |
$1.810 |
$1.865 |
risen by
3.04%
|
|
| Racura Oncology Ltd (RAC) ORDINARY FULLY PAID |
Health Care |
$475 |
Racura Investor Briefing Hong Kong and Singapore
|
3 Mar 2026 9:15AM |
$2.410 |
$2.540 |
risen by
5.39%
|
|
| Solstice Minerals Limited (SLS) ORDINARY FULLY PAID |
Materials |
$244 |
New High-Grade Zone Emerges at Nanadie Copper-Gold Project
|
3 Mar 2026 9:14AM |
$1.010 |
$1.420 |
risen by
40.59%
|
|
SLS - Price-sensitive ASX Announcement
Full Release
Key Points
- Discovery of new high-grade copper-gold zone at Nanadie.
- Phase 1 drilling program comprised of 23 holes over 6,030 meters.
- Significant copper-gold mineralisation identified beyond previous drilling.
- Plans for Phase 2 drilling to explore high-grade intercepts.
- Existing Inferred Mineral Resource Estimate of 40.4 million tonnes.
- Potential for expanding resource and project viability.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Nova Eye Medical Limited (EYE) ORDINARY FULLY PAID |
Health Care |
$36 |
EYE Receives EU MDR Certification
|
3 Mar 2026 9:14AM |
$0.145 |
$0.125 |
fallen by
13.79%
|
|
| Victory Metals Limited (VTM) ORDINARY FULLY PAID |
Materials |
$192 |
48x Rare Earth Upgrade to 5.9% TREO
|
3 Mar 2026 9:14AM |
$1.350 |
$1.460 |
risen by
8.15%
|
|
VTM - Price-sensitive ASX Announcement
Full Release
Key Points
- First-pass flotation test upgraded TREO concentration to 5.9%.
- Flotation enables rejection of over 95% of ore mass upstream.
- North Stanmore's mineralogy features secondary phosphates, aiding flotation.
- Hydrometallurgical plant size and costs significantly reduced.
- Maintains premium heavy rare earth ratio enriched in Dysprosium, Terbium, and Yttrium.
- Low levels of Uranium and Thorium reduce radioactive waste management needs.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| OMG Group Limited (OMG) ORDINARY FULLY PAID |
Consumer Staple |
$7 |
OMG to extend product ranging in Woolworths
|
3 Mar 2026 9:14AM |
$0.008 |
$0.007 |
fallen by
12.50%
|
|
OMG - Price-sensitive ASX Announcement
Full Release
Key Points
- OMG received a Letter of Acceptance from Woolworths for national product ranging.
- Three new flavours: Matcha & Strawberry, Banana & Peanut Butter, Salted Caramel.
- Total of five products in the PrOATein range now.
- New products to rollout nationally next quarter in 943 Woolworths stores.
- Expansion follows a successful Summer of Cricket campaign.
- Part of a broader multi-channel sales strategy, not exclusive to Woolworths.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Earlypay Ltd (EPY) ORDINARY FULLY PAID |
Financials |
$33 |
Update - Notification of buy-back - EPY
|
3 Mar 2026 9:13AM |
$0.160 |
$0.135 |
fallen by
15.63%
|
|
| Castle Minerals Limited (CDT) ORDINARY FULLY PAID |
Materials |
$9 |
Castle Expands Murchison Gold Footprint & Board Changes
|
3 Mar 2026 9:12AM |
$0.060 |
$0.050 |
fallen by
16.67%
|
|
CDT - Price-sensitive ASX Announcement
Full Release
Key Points
- Castle Minerals Limited expands its Murchison gold exploration footprint.
- Strategic increase in tenements in Western Australia's prospective gold region.
- Board changes announced to strengthen leadership.
- Focus on exploiting underexplored gold opportunities.
- Alignment with the company's strategy to enhance exploration activities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Xpedra Resources Limited (XPD) ORDINARY FULLY PAID |
Materials |
$14 |
Drilling Rig Mobilisation to Springfield Gold Deposit
|
3 Mar 2026 9:09AM |
$0.025 |
$0.021 |
fallen by
16%
|
|
| LinQ Minerals Limited (LNQ) ORDINARY FULLY PAID |
Materials |
$42 |
220m at 0.79% CuEq Intercepted from 99m at Mandamah
|
3 Mar 2026 9:08AM |
$0.520 |
$0.460 |
fallen by
11.54%
|
|
LNQ - Price-sensitive ASX Announcement
Full Release
Key Points
- Phase 1 drilling program completed at Mandamah deposit.
- Significant result: 220m @ 0.79% CuEq from 99m in hole MDACD001.
- Mandamah is part of the Gilmore Gold-Copper Project in NSW.
- Region known for porphyry copper and gold systems.
- Gilmore Project spans a 17km long mineralized corridor.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ariadne Australia Limited (ARA) ORDINARY FULLY PAID |
Industrials |
$89 |
Update - Notification of buy-back - ARA
|
3 Mar 2026 9:07AM |
$0.520 |
$0.460 |
fallen by
11.54%
|
|
| Ariadne Australia Limited (ARA) ORDINARY FULLY PAID |
Industrials |
$89 |
On-Market Buy-Back Facility Extended
|
3 Mar 2026 9:07AM |
$0.520 |
$0.460 |
fallen by
11.54%
|
|
| Nido Education Limited (NDO) ORDINARY FULLY PAID |
Consumer Discretionary |
$81 |
Update - Notification of buy-back - NDO
|
3 Mar 2026 9:07AM |
$0.460 |
$0.355 |
fallen by
22.83%
|
|
| L1 Global Long Short Fund Limited (GLS) ORDINARY FULLY PAID |
Financials |
$1,027 |
Change of Director's Interest Notice - Rachel Grimes AM
|
3 Mar 2026 9:07AM |
$2.080 |
$1.875 |
fallen by
9.86%
|
|
| Conrad Asia Energy Ltd (CRD) CHESS DEPOSITARY INTERESTS 1:1 |
Energy |
$96 |
Formal Approval of FID for Mako Gas Project
|
3 Mar 2026 9:07AM |
$0.600 |
$0.495 |
fallen by
17.50%
|
|
CRD - Price-sensitive ASX Announcement
Full Release
Key Points
- Conrad Asia Energy Ltd has formally approved the Final Investment Decision (FID) for the Mako Gas Project.
- The Mako Gas Project is located in the Duyung PSC in the Riau Islands Province of Indonesia.
- Full funding for the project, including contingencies, has been secured.
- The project transitioned from exploration to a development phase, targeting first gas by 4Q 2027.
- A gas sales agreement has been signed with PT PLN Energi Primer Indonesia, covering sales until 2037.
- Nations Petroleum Natuna Barat will fund 75% of future costs and carry portions of WNEL's costs through a Carry Loan Agreement.
- The project involves development wells and a leased Mobile Offshore Production Unit with a design capacity of 172 MMscfd.
- Conrad holds a 22.875% operated interest in the Duyung PSC.
- The project aims to deliver a clear path to production with a fully contracted revenue base.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bio-Gene Technology Ltd (BGT) ORDINARY FULLY PAID |
Materials |
$9 |
Regulatory Development of Flavocide
|
3 Mar 2026 9:05AM |
$0.033 |
$0.030 |
fallen by
9.09%
|
|
BGT - Price-sensitive ASX Announcement
Full Release
Key Points
- Flavocide development program is progressing with key toxicology studies underway.
- Initial toxicology results support further studies on reproductive and neurotoxicity.
- First regulatory submission to APVMA targeted for March 2027.
- Flavocide aimed at professional and domestic insecticide use, excluding use in food production.
- Data generated to OECD standards to support global regulatory submissions.
- Bio-Gene's strategy includes licensing and commercialization through partners.
- Flavocide's new mode of action addresses insecticide resistance.
- Future registration planned in the USA and other major markets.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Life360 Inc (360) CDI 3:1 FOREIGN EXEMPT XNGS |
Information Technology |
$3,327 |
Form S-8
|
3 Mar 2026 9:04AM |
$24.720 |
$18.390 |
fallen by
25.61%
|
|
Call 1300 880 160
Start a chat
Schedule a call
